The expression levels of CBX7 are reduced in some tumors, and it is correlated with the clinicopathological parameters of several tumors, including breast cancer, bladder cancer, colon cancer, and glioma [4,5,6,7]. Here, CBX7 is linked to colonic neoplasm.